Woodsmoke Particulate + Hypertonic Saline

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

September 12, 2024

Study Completion Date

September 12, 2024

Conditions
Airway Inflammation
Interventions
DEVICE

5% Hypertonic Saline

Immediately following exit from the wood smoke chamber, participants will inhale 15 mL of 5% Hypertonic Saline for 15 minutes delivered by Pari neb with a coached cough maneuver.

OTHER

No treatment

No inhaled treatment will be provided immediately following exit from the wood smoke chamber.

Trial Locations (1)

27599

Center for Environmental Medicine, Asthma and Lung Biology at UNC Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of North Carolina, Chapel Hill

OTHER

NCT03851406 - Woodsmoke Particulate + Hypertonic Saline | Biotech Hunter | Biotech Hunter